Chaysavanh Manichanh Institucions de les que formen part Cap de grup Recerca en microbioma Vall Hebron Institut de Recerca Email Chaysavanh Manichanh Email Institucions de les que formen part Cap de grup Recerca en microbioma Vall Hebron Institut de Recerca
Línies de recerca The Human Microbiome The Microbiome Research Group seeks to investigate the role of the microbiota in health and disease. Its secondary objectives include: 1. Role of the microbiota in health and disease 2. Tools to characterize the microbiome structure and function 3. Micro-biomarkers for diagnosis and prognosis 4. Fecal microbiota transplantation as a therapeutic strategy 5. Impact of diet on the gut microbial ecosystem IP: Chaysavanh Manichanh Gut Microbiota The human microbiome is the collective genomes of all microorganisms living at the multiple sites of the human body (oral cavity, skin, nasal cavity, gastrointestinal tract (GI) and vagina). Human (Homo sapiens) and their commensal microorganisms have evolved together over the last 200,000 years and have become dependent on one another. Interaction between humans and their symbiotic bacteria is essential to many aspects of normal ‘mammalian’ physiology, ranging from metabolic activity to immune homeostasis, and ecological or genetic changes that disturb this mutualism can result in disease. It reflects the evolutionary selection pressures acting at both the levels of the host and the microbial cells and has a direct profound impact on human health. This line of research aims at understanding the role of the gut microbiome in intestinal disorders using ‘omics approaches. Our research group proposes a service-collaboration in Microbiome analysis. You can find further information on our prices at the following URL. IP: Chaysavanh Manichanh Projectes El déficit de CFTR facilita la carcinogénesis pancreática y potencia el crecimiento, la agresividad tumoral y las metástasis IP: Chaysavanh Manichanh Col·laboradors: Laura Campderros Traver, Judit Álvarez González Entitat finançadora: Instituto de Salud Carlos III Finançament: 95000 Referència: CD22/00177 Durada: 01/03/2023 - 28/02/2025 Fisiologia i fisiopatologia digestiva IP: Chaysavanh Manichanh Col·laboradors: Itxarone Izaskun Bilbao Aguirre, Zaida Soler Luque, Jordi Barquinero Mañez, Oscar Segarra Canton, Gerard Serrano Gomez, Cristina Dopazo Taboada, Rocío Piñera Moreno, Zixuan Xie Entitat finançadora: AGAUR no fer servir-correcte 4301-37 Finançament: 40000 Referència: 2021 SGR 00459 Durada: 01/01/2022 - 31/12/2024 Evaluate the effect of diet on the gut microbial community IP: Chaysavanh Manichanh Col·laboradors: Zaida Soler Luque, Judit Álvarez González Entitat finançadora: Instituto de Salud Carlos III Finançament: 119567 Referència: FI21/00262 Durada: 01/01/2022 - 31/12/2025 Inflammatory Bowel Disease and Microbiome: Diagnosis and prediction of disease activity from the lab to the patients IP: Chaysavanh Manichanh Col·laboradors: - Entitat finançadora: Instituto de Salud Carlos III Finançament: 65000 Referència: CM21/00198 Durada: 01/01/2022 - 24/11/2022 Paginació Pàgina actual 1 Page 2 Page 3 Page 4 Page 5 … Pàgina següent › Última pàgina »
